Pacira Biosciences Inc PCRX:NASDAQ

Last Price$38.92NASDAQ Previous Close - Last Trade as of 4:00PM ET 10/17/19

Today's Change-0.11(0.28%)
Bid (Size)$38.91 (32)
Ask (Size)$39.45 (5)
Day Low / High$38.54 - 39.60
Volume535.6 K

Pacira Pharmaceuticals Says Data Show Its Pain Medication Cuts Opioid Use After Hip Surgery

8:13AM ET 6/12/2019 MT Newswires
Pacira Pharmaceuticals (PCRX) reported that new data that show that patients receiving EXPAREL after hip replacement surgery had a reduction in opioid use, hospital length of stay, and total hospitalization costs compared to patients who did not receive the product. The results were published in The Journal of Medical Economics.

EXPAREL (bupivacaine liposome injectable suspension) is indicated for single-dose infiltration in adults to produce postsurgical local analgesia, and as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia.

Price: 43.06, Change: +0.02, Percent Change: +0.05